Business Model Breakdown
How Colgate-Palmolive Co Makes Money
CL
Market Cap
$67.9B
Annual Revenue
$20.4B
Profit Margin
10.5%
Employees
34,000
The Short Version
Colgate-Palmolive is a global consumer products company that manufactures and markets a wide array of household, healthcare, personal care, and pet nutrition products. It makes money by selling these everyday essential goods, such as toothpastes, toothbrushes, soaps, detergents, and specialized pet food, to consumers worldwide through various retail channels, including supermarkets, hypermarkets, e-commerce, and specialized pet stores. The business model relies on strong brand recognition, extensive distribution networks, and continuous product innovation to maintain market leadership and consumer loyalty.
Where the Revenue Comes From
Oral Care products (~45% of total revenue - estimated based on historical trends)
Personal Care products (~20% of total revenue - estimated)
Home Care products (~15% of total revenue - estimated)
Pet Nutrition (Hill's) products (~20% of total revenue - estimated, fastest growing segment)
Who buys: Global consumers (individuals and households) and pet owners across various demographic and income segments.
Why It Works (Competitive Advantages)
- ✔Globally recognized brand portfolio (Colgate, Palmolive, Hill's)
- ✔Extensive global distribution network and supply chain efficiency
- ✔Significant scale providing cost advantages in procurement and manufacturing
Economic Moat: Wide (Brand Power, Cost Advantages, Intangible Assets/IP (product formulations))
What Our Analysis Says
DVR Score as of April 27, 2026
Colgate-Palmolive (CL) maintains its position as a stable consumer staples giant, with Q4 2025 earnings beating estimates and a modest 5.8% YoY revenue growth. The dividend increase further solidifies its appeal as an income investment. However, its core operations in mature markets, coupled with an analyst-projected EPS growth cut to 3-4% for 2026 and competition from private labels, severely limit its potential for 10x growth within 3-5 years. While it exhibits strong brand loyalty, its financial health presents some red flags, including a current ratio below 1.0 (0.83), quick ratio of 0.54, and very high debt-to-equity (18.82), which suggests an aggressive capital structure. These factors, alongside notes of core profitability erosion, underscore its unsuitability for high-growth, high-reward portfolios focused on exponential returns.